Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region.
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$276.00|
|52 Week High||NT$127.50|
|52 Week Low||NT$297.00|
|1 Month Change||4.55%|
|3 Month Change||22.67%|
|1 Year Change||77.49%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||115.64%|
Recent News & Updates
Tread With Caution Around Brighten Optix Corporation's (GTSM:6747) 2.0% Dividend Yield
Could Brighten Optix Corporation ( GTSM:6747 ) be an attractive dividend share to own for the long haul? Investors are...
|6747||TW Medical Equipment||TW Market|
Return vs Industry: 6747 exceeded the TW Medical Equipment industry which returned 5.4% over the past year.
Return vs Market: 6747 exceeded the TW Market which returned 33.6% over the past year.
Stable Share Price: 6747 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 6747's weekly volatility (6%) has been stable over the past year.
About the Company
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers its products under the Ortho-K myopia management lens, HiClear gas permeable (GP) lens, Briomoist lens care systems, SynergEyes hybrid lens, and Large Diameter GP lens. It also provides OEM/ODM collaboration services.
Is Brighten Optix undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 6747 (NT$276) is trading above our estimate of fair value (NT$258.66)
Significantly Below Fair Value: 6747 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 6747 is poor value based on its PE Ratio (29.4x) compared to the TW Medical Equipment industry average (22.8x).
PE vs Market: 6747 is poor value based on its PE Ratio (29.4x) compared to the TW market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 6747's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 6747 is overvalued based on its PB Ratio (6.7x) compared to the TW Medical Equipment industry average (2.1x).
How is Brighten Optix forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6747's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if 6747's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 6747's revenue (22.4% per year) is forecast to grow faster than the TW market (9.5% per year).
High Growth Revenue: 6747's revenue (22.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6747's Return on Equity is forecast to be high in 3 years time (33.6%)
How has Brighten Optix performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6747 has a large one-off gain of NT$100.2M impacting its June 30 2021 financial results.
Growing Profit Margin: 6747's current net profit margins (36.5%) are higher than last year (23.7%).
Past Earnings Growth Analysis
Earnings Trend: 6747's earnings have grown significantly by 21.4% per year over the past 5 years.
Accelerating Growth: 6747's earnings growth over the past year (96.7%) exceeds its 5-year average (21.4% per year).
Earnings vs Industry: 6747 earnings growth over the past year (96.7%) exceeded the Medical Equipment industry 9.5%.
Return on Equity
High ROE: 6747's Return on Equity (22.6%) is considered high.
How is Brighten Optix's financial position?
Financial Position Analysis
Short Term Liabilities: 6747's short term assets (NT$833.0M) exceed its short term liabilities (NT$234.4M).
Long Term Liabilities: 6747's short term assets (NT$833.0M) exceed its long term liabilities (NT$32.7M).
Debt to Equity History and Analysis
Debt Level: 6747 is debt free.
Reducing Debt: 6747 had no debt 5 years ago.
Debt Coverage: 6747 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6747 has no debt, therefore coverage of interest payments is not a concern.
What is Brighten Optix current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6747's dividend (1.95%) is higher than the bottom 25% of dividend payers in the TW market (1.94%).
High Dividend: 6747's dividend (1.95%) is low compared to the top 25% of dividend payers in the TW market (5.25%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether 6747's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 6747's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (54.4%), 6747's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 6747's dividends in 3 years are forecast to be covered by earnings (79.8% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Brighten Optix has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10%.
Brighten Optix Corporation's employee growth, exchange listings and data sources
- Name: Brighten Optix Corporation
- Ticker: 6747
- Exchange: TPEX
- Founded: NaN
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: NT$6.507b
- Shares outstanding: 24.19m
- Website: https://www.brightenoptix.com.tw
- Brighten Optix Corporation
- No.150, Chengde Road
- Taipei City
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/17 15:45|
|End of Day Share Price||2021/09/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.